APO Research
Talk to an analyst

APO RESEARCH · REPORT

Developmental and Reproductive Toxicology (DART) Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Developmental and Reproductive Toxicology (DART) Services Market Analysis and Forecast 2026-2032

12 August 2026174 pages

Choose your research edition.

Industry ResearchDevelopmental and Reproductive Toxicology (DART) Services Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Developmental and Reproductive Toxicology (DART) Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Developmental and Reproductive Toxicology (DART) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Developmental and Reproductive Toxicology (DART) Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Developmental and Reproductive Toxicology (DART) Services Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Developmental and Reproductive Toxicology (DART) Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Developmental and Reproductive Toxicology (DART) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Developmental and Reproductive Toxicology (DART) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Developmental and Reproductive Toxicology (DART) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Developmental and Reproductive Toxicology (DART) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Developmental and Reproductive Toxicology (DART) Services include AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron, Labcorp, RCC, Creative Biolabs and IITRI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Developmental and Reproductive Toxicology (DART) Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Developmental and Reproductive Toxicology (DART) Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Developmental and Reproductive Toxicology (DART) Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Developmental and Reproductive Toxicology (DART) Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Developmental and Reproductive Toxicology (DART) Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Developmental and Reproductive Toxicology (DART) Services revenue, projected growth trends, production technology, application and end-user industry.

Developmental and Reproductive Toxicology (DART) Services Segment by Company

AnaPath Services

Frontage

WuXi AppTec

Creative Animodel

Pharmaron

Labcorp

RCC

Creative Biolabs

IITRI

Syngene

JOINN

Inotiv

Accelera

Charles River

Developmental and Reproductive Toxicology (DART) Services Segment by Type

Fertility and Early Embryonic Development (FEED) study

Embryofetal Development (EFD) study

Pre- and Post-natal (PPND) study

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Application

Biotechnology

Academic Research

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Developmental and Reproductive Toxicology (DART) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Developmental and Reproductive Toxicology (DART) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Developmental and Reproductive Toxicology (DART) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Developmental and Reproductive Toxicology (DART) Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Developmental and Reproductive Toxicology (DART) Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Developmental and Reproductive Toxicology (DART) Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fertility and Early Embryonic Development (FEED) study Major Player Table 3. Embryofetal Development (EFD) study Major Player Table 4. Pre- and Post-natal (PPND) study Major Player Table 5. Others Major Player Table 6. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biotechnology Major Player Table 8. Academic Research Major Player Table 9. Others Major Player Table 10. Developmental and Reproductive Toxicology (DART) Services Industry Trends Table 11. Developmental and Reproductive Toxicology (DART) Services Industry Drivers Table 12. Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges Table 13. Developmental and Reproductive Toxicology (DART) Services Industry Restraints Table 14. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region (2021-2026) Table 17. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region (2027-2032) Table 19. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Players (2021-2026) Table 21. Global Developmental and Reproductive Toxicology (DART) Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Developmental and Reproductive Toxicology (DART) Services Key Players Headquarters & Area Served Table 23. Global Developmental and Reproductive Toxicology (DART) Services Players, Product Type & Application Table 24. Global Developmental and Reproductive Toxicology (DART) Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Developmental and Reproductive Toxicology (DART) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2021-2026) Table 31. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2027-2032) Table 32. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021-2026) Table 36. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2027-2032) Table 37. AnaPath Services Company Information Table 38. AnaPath Services Business Overview Table 39. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 41. AnaPath Services Recent Development Table 42. Frontage Company Information Table 43. Frontage Business Overview Table 44. Frontage Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 46. Frontage Recent Development Table 47. WuXi AppTec Company Information Table 48. WuXi AppTec Business Overview Table 49. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 51. WuXi AppTec Recent Development Table 52. Creative Animodel Company Information Table 53. Creative Animodel Business Overview Table 54. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 56. Creative Animodel Recent Development Table 57. Pharmaron Company Information Table 58. Pharmaron Business Overview Table 59. Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 61. Pharmaron Recent Development Table 62. Labcorp Company Information Table 63. Labcorp Business Overview Table 64. Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 66. Labcorp Recent Development Table 67. RCC Company Information Table 68. RCC Business Overview Table 69. RCC Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 71. RCC Recent Development Table 72. Creative Biolabs Company Information Table 73. Creative Biolabs Business Overview Table 74. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 76. Creative Biolabs Recent Development Table 77. IITRI Company Information Table 78. IITRI Business Overview Table 79. IITRI Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 81. IITRI Recent Development Table 82. Syngene Company Information Table 83. Syngene Business Overview Table 84. Syngene Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 86. Syngene Recent Development Table 87. JOINN Company Information Table 88. JOINN Business Overview Table 89. JOINN Developmental and Reproductive Toxicology (DART) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 91. JOINN Recent Development Table 92. Inotiv Company Information Table 93. Inotiv Business Overview Table 94. Inotiv Developmental and Reproductive Toxicology (DART) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 96. Inotiv Recent Development Table 97. Accelera Company Information Table 98. Accelera Business Overview Table 99. Accelera Developmental and Reproductive Toxicology (DART) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 101. Accelera Recent Development Table 102. Charles River Company Information Table 103. Charles River Business Overview Table 104. Charles River Developmental and Reproductive Toxicology (DART) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 106. Charles River Recent Development Table 107. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (US$ Million) & (2027-2032) Table 121. China Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 122. China Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 123. China Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 124. China Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Developmental and Reproductive Toxicology (DART) Services Image Figure 2. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Developmental and Reproductive Toxicology (DART) Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fertility and Early Embryonic Development (FEED) study Image Figure 5. Embryofetal Development (EFD) study Image Figure 6. Pre- and Post-natal (PPND) study Image Figure 7. Others Image Figure 8. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Developmental and Reproductive Toxicology (DART) Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biotechnology Image Figure 11. Academic Research Image Figure 12. Others Image Figure 13. Global Developmental and Reproductive Toxicology (DART) Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Developmental and Reproductive Toxicology (DART) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Developmental and Reproductive Toxicology (DART) Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2021-2032) Figure 21. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021-2032) Figure 24. North America Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032) Figure 26. North America Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032) Figure 27. North America Developmental and Reproductive Toxicology (DART) Services Revenue Share by Country (2021-2032) Figure 28. United States Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032) Figure 33. Europe Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032) Figure 34. Europe Developmental and Reproductive Toxicology (DART) Services Revenue Share by Country (2021-2032) Figure 35. Germany Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032) Figure 45. China Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032) Figure 46. Asia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032) Figure 48. Asia Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032) Figure 49. Asia Developmental and Reproductive Toxicology (DART) Services Revenue Share by Region (2021-2032) Figure 50. Japan Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue Share by Country (2021-2032) Figure 60. Brazil Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Developmental and Reproductive Toxicology (DART) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fertility and Early Embryonic Development (FEED) study
  • Embryofetal Development (EFD) study
  • Pre- and Post-natal (PPND) study
  • Others
Applications
  • Biotechnology
  • Academic Research
  • Others
Companies covered
  • AnaPath Services
  • Frontage
  • WuXi AppTec
  • Creative Animodel
  • Pharmaron
  • Labcorp
  • RCC
  • Creative Biolabs
  • IITRI
  • Syngene
  • JOINN
  • Inotiv
  • Accelera
  • Charles River

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Developmental and Reproductive Toxicology (DART) Services Market by Type
  3. 1.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fertility and Early Embryonic Development (FEED) study
  5. 1.2.3 Embryofetal Development (EFD) study
  6. 1.2.4 Pre- and Post-natal (PPND) study
  7. 1.2.5 Others
  8. 1.3 Developmental and Reproductive Toxicology (DART) Services Market by Application
  9. 1.3.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biotechnology
  11. 1.3.3 Academic Research
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Developmental and Reproductive Toxicology (DART) Services Market Dynamics
  1. 2.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
  2. 2.2 Developmental and Reproductive Toxicology (DART) Services Industry Drivers
  3. 2.3 Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges
  4. 2.4 Developmental and Reproductive Toxicology (DART) Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Developmental and Reproductive Toxicology (DART) Services Market Perspective (2021-2032)
  2. 3.2 Global Developmental and Reproductive Toxicology (DART) Services Growth Trends by Region
  3. 3.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Players
  2. 4.1.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Developmental and Reproductive Toxicology (DART) Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Developmental and Reproductive Toxicology (DART) Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Developmental and Reproductive Toxicology (DART) Services Key Players Headquarters & Area Served
  7. 4.4 Global Developmental and Reproductive Toxicology (DART) Services Players, Product Type & Application
  8. 4.5 Global Developmental and Reproductive Toxicology (DART) Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Developmental and Reproductive Toxicology (DART) Services Market CR5 and HHI
  11. 4.6.3 2025 Developmental and Reproductive Toxicology (DART) Services Tier 1, Tier 2, and Tier 3
5 Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  1. 5.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 5.3 Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2021-2032)
6 Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  1. 6.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  3. 6.3 Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AnaPath Services
  2. 7.1.1 AnaPath Services Company Information
  3. 7.1.2 AnaPath Services Business Overview
  4. 7.1.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  6. 7.1.5 AnaPath Services Recent Developments
  7. 7.2 Frontage
  8. 7.2.1 Frontage Company Information
  9. 7.2.2 Frontage Business Overview
  10. 7.2.3 Frontage Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  12. 7.2.5 Frontage Recent Developments
  13. 7.3 WuXi AppTec
  14. 7.3.1 WuXi AppTec Company Information
  15. 7.3.2 WuXi AppTec Business Overview
  16. 7.3.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  18. 7.3.5 WuXi AppTec Recent Developments
  19. 7.4 Creative Animodel
  20. 7.4.1 Creative Animodel Company Information
  21. 7.4.2 Creative Animodel Business Overview
  22. 7.4.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  24. 7.4.5 Creative Animodel Recent Developments
  25. 7.5 Pharmaron
  26. 7.5.1 Pharmaron Company Information
  27. 7.5.2 Pharmaron Business Overview
  28. 7.5.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  30. 7.5.5 Pharmaron Recent Developments
  31. 7.6 Labcorp
  32. 7.6.1 Labcorp Company Information
  33. 7.6.2 Labcorp Business Overview
  34. 7.6.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  36. 7.6.5 Labcorp Recent Developments
  37. 7.7 RCC
  38. 7.7.1 RCC Company Information
  39. 7.7.2 RCC Business Overview
  40. 7.7.3 RCC Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  42. 7.7.5 RCC Recent Developments
  43. 7.8 Creative Biolabs
  44. 7.8.1 Creative Biolabs Company Information
  45. 7.8.2 Creative Biolabs Business Overview
  46. 7.8.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  48. 7.8.5 Creative Biolabs Recent Developments
  49. 7.9 IITRI
  50. 7.9.1 IITRI Company Information
  51. 7.9.2 IITRI Business Overview
  52. 7.9.3 IITRI Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  54. 7.9.5 IITRI Recent Developments
  55. 7.10 Syngene
  56. 7.10.1 Syngene Company Information
  57. 7.10.2 Syngene Business Overview
  58. 7.10.3 Syngene Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  60. 7.10.5 Syngene Recent Developments
  61. 7.11 JOINN
  62. 7.11.1 JOINN Company Information
  63. 7.11.2 JOINN Business Overview
  64. 7.11.3 JOINN Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  66. 7.11.5 JOINN Recent Developments
  67. 7.12 Inotiv
  68. 7.12.1 Inotiv Company Information
  69. 7.12.2 Inotiv Business Overview
  70. 7.12.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  72. 7.12.5 Inotiv Recent Developments
  73. 7.13 Accelera
  74. 7.13.1 Accelera Company Information
  75. 7.13.2 Accelera Business Overview
  76. 7.13.3 Accelera Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  78. 7.13.5 Accelera Recent Developments
  79. 7.14 Charles River
  80. 7.14.1 Charles River Company Information
  81. 7.14.2 Charles River Business Overview
  82. 7.14.3 Charles River Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  84. 7.14.5 Charles River Recent Developments
8 North America
  1. 8.1 North America Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2032)
  2. 8.2 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032)
  5. 8.3 North America Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032)
  9. 8.5 North America Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country
  11. 8.6.1 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2032)
  2. 9.2 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032)
  5. 9.3 Europe Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032)
  9. 9.5 Europe Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country
  11. 9.6.1 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2032)
  2. 10.2 China Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 10.2.1 China Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026)
  4. 10.2.2 China Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032)
  5. 10.3 China Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032)
  6. 10.4 China Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  7. 10.4.1 China Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026)
  8. 10.4.2 China Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032)
  9. 10.5 China Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2032)
  2. 11.2 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032)
  5. 11.3 Asia Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032)
  9. 11.5 Asia Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Country
  11. 11.6.1 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2032)
  2. 12.2 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country
  11. 12.6.1 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Developmental and Reproductive Toxicology (DART) Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst